340Basics Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • 340Basics's estimated annual revenue is currently $15M per year.(i)
  • 340Basics's estimated revenue per employee is $106,383

Employee Data

  • 340Basics has 141 Employees.(i)
  • 340Basics grew their employee count by 31% last year.

340Basics's People

NameTitleEmail/Phone
1
VP SalesReveal Email/Phone
2
VP Pharmacy OperationsReveal Email/Phone
3
Director Marketing and CommunicationsReveal Email/Phone
4
Director Clinical ServicesReveal Email/Phone
5
ETL ManagerReveal Email/Phone
6
Account ManagerReveal Email/Phone
7
Account ManagerReveal Email/Phone
8
Inside Sales SpecialistReveal Email/Phone
9
Inside Sales ManagerReveal Email/Phone
10
Business Intelligence and Reporting Team LeadReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A3737%N/AN/A
#2
N/A1196%N/AN/A
#3
N/A2932%N/AN/A
#4
N/A65423%N/AN/A
#5
$7.5M36-12%N/AN/A
#6
N/A642%N/AN/A
#7
N/A2750%N/AN/A
#8
$7.5M716%N/AN/A
#9
N/A62528%N/AN/A
#10
N/A2556%N/AN/A
Add Company

What Is 340Basics?

340Basics is at the forefront of healthcare technology, delivering cutting-edge software solutions to all 340B-eligible healthcare providers and pharmacies. 340Basics was developed and brought to life by industry experts whose vast knowledge enables us to deliver superior products that are powerful, user-friendly and increase your savings. We provide all this while seamlessly acting as an extension of your business, providing real-time data and transparency. 340Basics understands that needs differ between diverse clients, which is why our software and consulting services are adapted and customized to each of our client’s needs. We are the top tier leaders in our field.

keywords:N/A

N/A

Total Funding

141

Number of Employees

$15M

Revenue (est)

31%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15M1419%N/A
#2
$46.3M1563%N/A
#3
$35M1586%N/A
#4
$29.6M1688%N/A
#5
$54.1M1820%N/A